Accordingly, ERα stimulation and ERβ inhibition were found to promote the survival and growth of PTC tumor cells in a dose-dependent manner, whereas ERα inhibition and ERβ stimulation led to the opposite effects. The gene discussed is ESR2; the disease is neoplasm.